Associate Director
US$186,000 – US$233,000 / yr base salary
Posted 1 Jul 2026
Advertised as “Associate Director, Precision Medicine & Companion Diagnostics”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 7–10 yrs
- Management level
- People management
- Employment
- Hybrid
- Contract
- Full-time
| Base salary | US$186,000 – US$233,000 / yr |
|---|
Study levelMaster's or higher
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is offering a highly visible opportunity for talented and motivated individual to join our Precision Medicine Companion Diagnostics team as an Associate Director, Companion Diagnostics within the Translational Medicine function, which supports CDx development across RevMed portfolio. Through both scientific and cross-functional leadership, individual is to implement global diagnostic strategies to enable and support the global development and commercialization of medically differentiated therapies. The successful candidate will have the opportunity to work in a fast-paced, highly collaborative environment and will be a key member of multidisciplinary development project teams.
Required Skills, Experience and Education:
-
Lead the development and implementation of diagnostic strategies through registration and launch for individual clinical studies and/or molecule program.
-
Direct the development, outsourcing and validation of clinically applicable in vitro diagnostic assays through the development lifecycle of molecules, including design, implement and oversee diagnostic testing and registration strategy and timely communication with key internal and external stakeholders.
-
Provide expertise to development project teams to ensure access to state-of-the-art approaches on appropriate diagnostic technologies (e.g. NGS-based tissue and ctDNA assays, PCR, immunohistochemistry), evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to the proposed companion diagnostic assay.
-
Oversee implementation of clinical trial assays at CRO laboratories for centralized testing supporting clinical trials. Monitors all scope or changes in study are timely implemented, including the development of the work order, costs and agreements.
-
Lead joint development teams between RevMed and Dx partners to ensure cross-functional alignment of overarching development, regulatory and commercialization strategy, successful fit for purpose CDx development and that co-development timelines are met.